Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068938238> ?p ?o ?g. }
- W2068938238 endingPage "250" @default.
- W2068938238 startingPage "239" @default.
- W2068938238 abstract "Diabetic retinopathy remains one of the major causes of acquired blindness in developed nations. This is true despite the development of laser treatment, which can prevent blindness in the majority of those who develop macular oedema (ME) or proliferative diabetic retinopathy (PDR). ME is manifest by retinal vascular leakage and thickening of the retina. The hallmark of PDR is neovascularisation (NV)--abnormal angiogenesis that may ultimately cause severe vitreous cavity bleeding and/or retinal detachment. Pharmacologic therapy aimed specifically at preventing vascular leakage and NV would be a welcome addition to the armamentarium. PDR and ME could be prevented by improved metabolic control or by pharmacologically blunting the biochemical consequences of hyperglycaemia (e.g., with aldose reductase inhibitors, inhibitors of non-enzymatic glycation or by protein kinase C [PKC] inhibition). The angiogenesis in PDR could be treated via growth factor (e.g., vascular endothelial growth factor [VEGF], insulin like growth factor-1 [IGF-1]) blockade, integrin (e.g., alpha-v beta-3) blockade, extracellular matrix alteration (e.g., with steroid compounds) or interference with intracellular signal transduction pathways (e.g., PKC and mitogen activated protein kinase [MAPK] pathway proteins). Some of these antiangiogenic agents may also prove useful for treating or preventing ME. Numerous potentially useful antiangiogenic compounds are in development; two drugs are presently in clinical trials for treatment of the preproliferative stage of PDR, while two are in clinical trials for treatment of ME." @default.
- W2068938238 created "2016-06-24" @default.
- W2068938238 creator A5029142735 @default.
- W2068938238 creator A5035811477 @default.
- W2068938238 creator A5056249618 @default.
- W2068938238 creator A5073368543 @default.
- W2068938238 date "2003-05-01" @default.
- W2068938238 modified "2023-09-26" @default.
- W2068938238 title "Pharmacologic therapy for diabetic retinopathy" @default.
- W2068938238 cites W1562028693 @default.
- W2068938238 cites W1886431664 @default.
- W2068938238 cites W1967172766 @default.
- W2068938238 cites W1971634822 @default.
- W2068938238 cites W1974018871 @default.
- W2068938238 cites W1984654408 @default.
- W2068938238 cites W1988143227 @default.
- W2068938238 cites W1988202224 @default.
- W2068938238 cites W1994594825 @default.
- W2068938238 cites W1997926000 @default.
- W2068938238 cites W2001419850 @default.
- W2068938238 cites W2006169025 @default.
- W2068938238 cites W2010072380 @default.
- W2068938238 cites W2012564902 @default.
- W2068938238 cites W2018586410 @default.
- W2068938238 cites W2022080575 @default.
- W2068938238 cites W2025732390 @default.
- W2068938238 cites W2027709249 @default.
- W2068938238 cites W2033887376 @default.
- W2068938238 cites W2037623358 @default.
- W2068938238 cites W2039317622 @default.
- W2068938238 cites W2039410387 @default.
- W2068938238 cites W2052904401 @default.
- W2068938238 cites W2055168506 @default.
- W2068938238 cites W2055696255 @default.
- W2068938238 cites W2056921364 @default.
- W2068938238 cites W2061999745 @default.
- W2068938238 cites W2063446370 @default.
- W2068938238 cites W2063676096 @default.
- W2068938238 cites W2065550467 @default.
- W2068938238 cites W2068472192 @default.
- W2068938238 cites W2069485863 @default.
- W2068938238 cites W2069594832 @default.
- W2068938238 cites W2074609211 @default.
- W2068938238 cites W2077302000 @default.
- W2068938238 cites W2081417168 @default.
- W2068938238 cites W2082730029 @default.
- W2068938238 cites W2094723834 @default.
- W2068938238 cites W2097602902 @default.
- W2068938238 cites W2098972920 @default.
- W2068938238 cites W2104738423 @default.
- W2068938238 cites W2106527155 @default.
- W2068938238 cites W2106840754 @default.
- W2068938238 cites W2112686297 @default.
- W2068938238 cites W2118836695 @default.
- W2068938238 cites W2120723151 @default.
- W2068938238 cites W2125355416 @default.
- W2068938238 cites W2129949645 @default.
- W2068938238 cites W2131570525 @default.
- W2068938238 cites W2137205646 @default.
- W2068938238 cites W2141972913 @default.
- W2068938238 cites W2144342344 @default.
- W2068938238 cites W2146587653 @default.
- W2068938238 cites W2169265493 @default.
- W2068938238 cites W2337705118 @default.
- W2068938238 cites W2612281319 @default.
- W2068938238 cites W2767261857 @default.
- W2068938238 cites W296366829 @default.
- W2068938238 cites W299656855 @default.
- W2068938238 cites W3198570063 @default.
- W2068938238 cites W3202352366 @default.
- W2068938238 cites W4233230329 @default.
- W2068938238 cites W4234357427 @default.
- W2068938238 cites W4235291177 @default.
- W2068938238 cites W4238170927 @default.
- W2068938238 cites W4242344507 @default.
- W2068938238 cites W4245029649 @default.
- W2068938238 cites W4245344909 @default.
- W2068938238 cites W4255138787 @default.
- W2068938238 cites W4255217632 @default.
- W2068938238 doi "https://doi.org/10.1517/14728214.8.1.239" @default.
- W2068938238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14610924" @default.
- W2068938238 hasPublicationYear "2003" @default.
- W2068938238 type Work @default.
- W2068938238 sameAs 2068938238 @default.
- W2068938238 citedByCount "23" @default.
- W2068938238 countsByYear W20689382382014 @default.
- W2068938238 countsByYear W20689382382016 @default.
- W2068938238 countsByYear W20689382382022 @default.
- W2068938238 crossrefType "journal-article" @default.
- W2068938238 hasAuthorship W2068938238A5029142735 @default.
- W2068938238 hasAuthorship W2068938238A5035811477 @default.
- W2068938238 hasAuthorship W2068938238A5056249618 @default.
- W2068938238 hasAuthorship W2068938238A5073368543 @default.
- W2068938238 hasConcept C126322002 @default.
- W2068938238 hasConcept C134018914 @default.
- W2068938238 hasConcept C167734588 @default.
- W2068938238 hasConcept C195794163 @default.
- W2068938238 hasConcept C2777025900 @default.